AbbVie
ABBV
ABBV
3,761 hedge funds and large institutions have $241B invested in AbbVie in 2025 Q2 according to their latest regulatory filings, with 180 funds opening new positions, 1,696 increasing their positions, 1,464 reducing their positions, and 166 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 3,800 → 3,761 (-39)
9% less capital invested
Capital invested by funds: $265B → $241B (-$23.4B)
39% less funds holding in top 10
Funds holding in top 10: 246 → 150 (-96)
Holders
3,761
Holding in Top 10
150
Calls
$3.23B
Puts
$2.09B
Top Buyers
| 1 | +$681M | |
| 2 | +$628M | |
| 3 | +$552M | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$512M |
| 5 |
JP Morgan Chase
New York
|
+$457M |
Top Sellers
| 1 | -$1.8B | |
| 2 | -$1.53B | |
| 3 | -$1.28B | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$581M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$529M |